Skip to main content
. 2017 Aug 17;7:8535. doi: 10.1038/s41598-017-08906-x

Table 2.

Number of CSF samples with detectable and quantifiable ivermectin divided by study phase and treatment group.

Concentration Phase I Phase II
Ivm Ivm Ket Rif
 < 0.1 ng/ml 20 10 10 13
 > 0.1 < 0.5 ng/ml 4 0 2 2
Total 24 10 12 15

Footnote: Ivm: ivermectin only group, Ket: ketoconazole + ivermectin group, Rif: rifampicin + ivermectin group.